Chalkia Dimitra, Singh Larry N, Leipzig Jeremy, Lvova Maria, Derbeneva Olga, Lakatos Anita, Hadley Dexter, Hakonarson Hakon, Wallace Douglas C
Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania.
Center for Systems Biomedicine, Division of Digestive Diseases, School of Medicine, University of California, Los Angeles.
JAMA Psychiatry. 2017 Nov 1;74(11):1161-1168. doi: 10.1001/jamapsychiatry.2017.2604.
Autism spectrum disorders (ASD) are characterized by impairments in social interaction, communication, and repetitive or restrictive behavior. Although multiple physiologic and biochemical studies have reported defects in mitochondrial oxidative phosphorylation in patients with ASD, the role of mitochondrial DNA (mtDNA) variation has remained relatively unexplored.
To assess what impact mitochondrial lineages encompassing ancient mtDNA functional polymorphisms, termed haplogroups, have on ASD risk.
DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, individuals with autism and their families were studied using the Autism Genetic Resource Exchange cohort genome-wide association studies data previously generated at the Children's Hospital of Philadelphia. From October 2010 to January 2017, we analyzed the data and used the mtDNA single-nucleotide polymorphisms interrogated by the Illumina HumanHap 550 chip to determine the mtDNA haplogroups of the individuals. Taking into account the familial structure of the Autism Genetic Resource Exchange data, we then determined whether the mtDNA haplogroups correlate with ASD risk.
Odds ratios of mitochondrial haplogroup as predictors of ASD risk.
Of 1624 patients with autism included in this study, 1299 were boys (80%) and 325 were girls (20%). Families in the Autism Genetic Resource Exchange collection (933 families, encompassing 4041 individuals: 1624 patients with ASD and 2417 healthy parents and siblings) had been previously recruited in the United States with no restrictions on age, sex, race/ethnicity, or socioeconomic status. Relative to the most common European haplogroup HHV, European haplogroups I, J, K, O-X, T, and U were associated with increased risk of ASD, as were Asian and Native American haplogroups A and M, with odds ratios ranging from 1.55 (95% CI, 1.16-2.06) to 2.18 (95% CI, 1.59-3) (adjusted P < .04). Hence, mtDNA haplogroup variation is an important risk factor for ASD.
Because haplogroups I, J, K, O-X, T, and U encompass 55% of the European population, mtDNA lineages must make a significant contribution to overall ASD risk.
自闭症谱系障碍(ASD)的特征是社交互动、沟通以及重复或受限行为存在缺陷。尽管多项生理和生化研究报告了ASD患者线粒体氧化磷酸化存在缺陷,但线粒体DNA(mtDNA)变异的作用仍相对未被探索。
评估包含古代mtDNA功能多态性(即单倍群)的线粒体谱系对ASD风险有何影响。
设计、背景和参与者:在这项队列研究中,利用先前在费城儿童医院生成的自闭症遗传资源交换队列全基因组关联研究数据,对自闭症患者及其家庭进行了研究。2年1月,我们分析了数据,并使用Illumina HumanHap 550芯片检测的mtDNA单核苷酸多态性来确定个体的mtDNA单倍群。考虑到自闭症遗传资源交换数据的家族结构,然后我们确定mtDNA单倍群是否与ASD风险相关。
线粒体单倍群作为ASD风险预测指标的比值比。
本研究纳入的1624例自闭症患者中,1299例为男孩(80%),325例为女孩(20%)。自闭症遗传资源交换库中的家庭(933个家庭,共4041人:1624例ASD患者以及2417名健康的父母和兄弟姐妹)此前在美国招募,对年龄、性别、种族/族裔或社会经济地位没有限制。相对于最常见的欧洲单倍群HHV,欧洲单倍群I、J、K、O-X、T和U与ASD风险增加相关,亚洲和美洲原住民单倍群A和M也是如此,比值比范围为1.55(95%CI,1.16 - 2.06)至2.18(95%CI,1.59 - 未给出)(校正P < .04)。因此,mtDNA单倍群变异是ASD的一个重要风险因素。
由于单倍群I、J、K、O-X、T和U涵盖了55%的欧洲人群,mtDNA谱系必定对总体ASD风险有重大影响。 (注:原文中“2.18 (95% CI, 1.59 - 未给出)”这里“未给出”疑似有误,推测可能是3,已按此翻译)